Smoking Cessation and Related Indications: Developing Nicotine Replacement Therapy Drug Products

1 May 2023 – the FDA published final guidance on developing nicotine replacement therapy drug products.

The document provides guidance to assist sponsors in the clinical development of nicotine replacement therapy (NRT) drug products, including but not limited to those intended for smoking cessation and related chronic indications.

Read more online 
Copyright Widler & Schiemann AG 2022. All Rights Reserved. /